Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Hyatt Regency Bethesda

01 oct 2013 8:30 a.m. - 02 oct 2013 3:30 p.m.

One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814-5326

Clinical Trial Disclosure: Towards a More Transparent World

Featured

Want to learn more about Clinical Trial Disclosure: Towards a More Transparent World? You've come to the right site!

Continuing-Education

Short Course or Primer

To keep you at the forefront.

30 sep 2013

Clinical Trial Disclosure Tutorial 1:

A Sane Approach to Entering Results in ClinicalTrials.gov

30 sep 2013

Tutorial 2:

Is Your Protocol Ready to Be Published

Comité del programa

  • Marla Jo  Brickman, PHD
    Marla Jo Brickman, PHD Senior Director - Clinical Data Transparency/Compassionate Access Lead
    Pfizer Inc, United States
  • Robert  Paarlberg, MS
    Robert Paarlberg, MS Principal
    Paarlberg & Associates LLC, United States
  • Mark  Barnes, JD, LLM
    Mark Barnes, JD, LLM Partner
    Ropes & Gray, LLP, United States
  • Christopher  Dedels
    Christopher Dedels
    Virtify, Inc, United States
  • Peter  Doshi, PHD
    Peter Doshi, PHD Postdoctoral Fellow in CER Divisions of Gen Pediatrics & Gen Internal Medicine
    Johns Hopkins University School of Medicine, United States
  • Jarilyn  Dupont, JD
    Jarilyn Dupont, JD Director of Regulatory Policy, Office of Policy, OC
    FDA, United States
  • Chris  Galvin
    Chris Galvin Office of Inspector General
    Department of Health and Human Services, United States
  • Jessica  Gilbart, MS
    Jessica Gilbart, MS Director of Patient Services
    Lupus Foundation of America, United States
  • Laura A. Hagan
    Laura A. Hagan Global Head Clinical Disclosure Office
    Novartis Pharmaceuticals Corporation, United States
  • Cheryl J. Jernigan
    Cheryl J. Jernigan Member, Advocates in Science Steering Committee
    Susan G. Komen For the Cure, United States
  • Michel  Krumenacker, MD
    Michel Krumenacker, MD Retired
    Retired - Formerly Sanofi, United States
  • Christine  Laine, MD, MPH
    Christine Laine, MD, MPH Senior Vice President; Editor, Annals of Internal Medicine
    American College of Physicians, United States
  • Rebecca  Li, PHD
    Rebecca Li, PHD Executive Director, Center for Global Clinical Research Data
    Vivli , United States
  • Ana  Rodriguez Sanchez Beato , PHD
    Ana Rodriguez Sanchez Beato , PHD Head of Clinical and Non-Clinical Compliance, CTIS expert
    European Medicines Agency, Netherlands
  • Joseph  Ross, MD, MHS
    Joseph Ross, MD, MHS Professor of Medicine and Public Health
    Yale University School of Medicine, United States
  • Ahmed R. Saleh, PHD, MS
    Ahmed R. Saleh, PHD, MS Director, Clinical Trials; Laboratory of Viral Diagnostics
    University of Maryland, United States
  • Shannon  Tyson
    Shannon Tyson Manager, Clinical Trial Disclosure Group
    Pfizer Inc., United States
  • Sarah A. White, MPH
    Sarah A. White, MPH Executive Director
    MRCT Center, United States
  • Thomas  Wicks, MBA
    Thomas Wicks, MBA Head of Transparency Operations
    Citeline, United States
  • Deborah A. Zarin, DrMed, MD
    Deborah A. Zarin, DrMed, MD Faculty, Harvard Medical Center; Program Director
    MRCT Center, United States
  • Tracy  Beck
    Tracy Beck
    Eli Lilly and Company, United States
  • Barbara  Godlew, RN
    Barbara Godlew, RN Associate Consultant, Scientific Communications, GSC-Bio-Medicines
    Eli Lilly and Company, United States
  • Karen  Hartman, MSN, RN
    Karen Hartman, MSN, RN Research Compliance Officer
    Mayo Clinic, United States
  • Merete  Joergensen, MBA, MSC
    Merete Joergensen, MBA, MSC Clinical Disclosure and Transparency Expert
    Merete-J Consulting, Denmark
  • Erik  Lakes, MS, MSC
    Erik Lakes, MS, MSC Senior Director and Head, Data Disclosure & Transparency
    Beigene, United States
  • Hanns-Georg  Leimer, PHD
    Hanns-Georg Leimer, PHD Global Head Central Solutions and Services Medicine (CSSM) in Global Biostatisti
    Boehringer Ingelheim Pharma GmbH&CO KG, Germany
  • Melanie  North, PHD
    Melanie North, PHD Manager, Clinical Trial Transparency and Disclosure
    United States
  • Patricia  Teden, MBA
    Patricia Teden, MBA President and Principal
    Teden Consulting LLC, United States

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.